Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer
- 1 January 1999
- journal article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 82 (1) , 107-110
- https://doi.org/10.1016/s0301-2115(98)00227-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Serum Evaluation of Interleukin 6 in Ovarian Cancer PatientsGynecologic Oncology, 1997
- Pre-operative plasma levels of C-reactive protein, albumin and various plasma protease inhibitors for the pre-operative assessment of operability and recurrence in cancer surgeryEuropean Journal of Surgical Oncology, 1996
- Higher levels of interleukin-6 in cystic fluids from patients with malignant versus benign ovarian tumors correlate with decreased hemoglobin levels and increased platelet countsCancer, 1995
- Interleukin‐6 serum levels in patients with gynecological tumorsInternational Journal of Cancer, 1994
- Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancerCancer, 1994
- Cancer of the OvaryNew England Journal of Medicine, 1993
- Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancerCancer, 1993
- High IL‐6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancerBritish Journal of Haematology, 1993
- Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1991
- Elevated Circulating Interleukin-6 Is Associated with an Acute-phase Response but Reduced Fixed Hepatic Protein Synthesis in Patients with CancerAnnals of Surgery, 1991